Back

Population Age-Ineligible for COVID-19 Vaccine in the United States: Implications for State, County, and Race/Ethnicity Vaccination Targets

Pathak, E. B.; Menard, J.; Garcia, R.

2021-02-15 public and global health
10.1101/2021.02.11.21251562
Show abstract

BackgroundWe examined the geographic and racial/ethnic distribution of the SARS-CoV-2 vaccine age-ineligible population (0-15 years old) in the U.S., and calculated the proportion of the age-eligible population that will need to be vaccinated in a given geo-demographic group in order to achieve either 60% or 75% vaccine coverage for that population as a whole. MethodsUS Census Bureau population estimates for 2019 were used to calculate the percent vaccine ineligible and related measures for counties, states, and the nation as a whole. Vaccination targets for the 30 largest counties by population were calculated. Study measures were calculated for racial/ethnic populations at the national (n=7) and state (n=6) levels. ResultsPercent of population ineligible for vaccine varied widely both geographically and by race/ethnicity. State values ranged from 15.8% in Vermont to 25.7% in Utah, while percent ineligible of the major racial/ethnic groups was 16.4% of non-Hispanic whites, 21.6% of non-Hispanic Blacks, and 27.5% of Hispanics. Achievement of total population vaccine coverage of at least 75% will require vaccinating more than 90% of the population aged 16 years and older in 29 out of 30 of the largest counties in the U.S. ConclusionsThe vaccine-ineligibility of most children for the next 1-2 years, coupled with reported pervasive vaccine hesitancy among adults, especially women and most minorities, means that achievement of adequate levels of vaccine coverage will be very difficult for many vulnerable geographic areas and for several racial/ethnic minority groups, particularly Hispanics, Blacks, and American Indians.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Vaccine
based on 140 papers
Top 0.4%
15.9%
2
PLOS ONE
based on 1737 papers
Top 39%
13.0%
3
Vaccines
based on 131 papers
Top 0.8%
7.8%
4
JAMA Network Open
based on 125 papers
Top 1%
7.8%
5
Clinical Infectious Diseases
based on 219 papers
Top 5%
5.5%
50% of probability mass above
6
American Journal of Preventive Medicine
based on 11 papers
Top 0.1%
4.9%
7
Vaccine: X
based on 16 papers
Top 0.2%
2.9%
8
BMC Public Health
based on 148 papers
Top 8%
2.9%
9
The Lancet Regional Health - Americas
based on 20 papers
Top 0.1%
2.4%
10
Human Vaccines & Immunotherapeutics
based on 20 papers
Top 0.7%
2.4%
11
Frontiers in Public Health
based on 135 papers
Top 15%
1.8%
12
BMJ Open
based on 553 papers
Top 38%
1.8%
13
Preventive Medicine Reports
based on 14 papers
Top 0.5%
1.8%
14
PLOS Medicine
based on 95 papers
Top 8%
1.6%
15
JMIR Public Health and Surveillance
based on 45 papers
Top 5%
1.6%
16
American Journal of Epidemiology
based on 54 papers
Top 4%
1.4%
17
Nature Communications
based on 483 papers
Top 36%
1.2%
18
Pediatrics
based on 10 papers
Top 1%
0.8%
19
Open Forum Infectious Diseases
based on 124 papers
Top 9%
0.8%
20
Nature Medicine
based on 88 papers
Top 15%
0.8%
21
The Journal of Pediatrics
based on 15 papers
Top 2%
0.8%
22
Annals of Epidemiology
based on 19 papers
Top 2%
0.7%
23
Emerging Infectious Diseases
based on 84 papers
Top 12%
0.7%
24
The Lancet Infectious Diseases
based on 57 papers
Top 8%
0.7%
25
Journal of Racial and Ethnic Health Disparities
based on 11 papers
Top 1%
0.7%